News
BIO 2025 this year came at a uniquely fraught moment for vaccination in the United States just days after HHS Secretary ...
On oncological hope at ASCO 2025: In conversation with City of Hope Orange County's Dr Pashtoon Kasi
Liquid biopsies are reshaping colon cancer detection, particularly in addressing the rise in early-onset cases.
Kymera Therapeutics is celebrating the signing of two partnerships, with Gilead Sciences taking an option on one molecular ...
That is the conclusion of a study in The Lancet, which has tracked the take-up of childhood vaccinations for diseases like ...
Elevidys has been given full approval to treat ambulatory patients with DMD, with an accelerated approval in non-ambulatory ...
Trying to tackle all challenges at once will likely cause even more issues in the future; instead of spreading out, focus on ...
The STAAR trial showed that a one-shot dose of ST-920 – now known as isaralgagene civaparvovec – was able to improve kidney ...
The EU approval is the first for the drug, although the FDA in the US is due to deliver its verdict on it by 29th July, and ...
AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) Datroway has been granted accelerated approval ...
Lung cancer proved the second-most discussed cancer type during ASCO 2025, totalling 2,995 mentions by more than 530 HCPs. As ...
In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...
Antibody-drug conjugates (ADCs) hit the scene in oncology many moons ago – in fact, this year marks 25 years since the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results